ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Nasal Polyps
Allergic Rhinitis
Rhinitis
Rhinosinusitis
Respiration Disorders
Respiratory Tract Diseases

Asthma trials near New Haven, CT, USA:

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (EXHALE-4)

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Enrolling
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Hawthorne, New York, United States and 209 other locations

To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...

Active, not recruiting
Asthma
Drug: Tezepelumab

Phase 4

AstraZeneca
AstraZeneca

New Haven, Connecticut, United States and 34 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Hawthorne, New York, United States and 57 other locations

Locations recently updated

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling
Asthma
Drug: Atuliflapon
Drug: Placebo

Phase 2

AstraZeneca
AstraZeneca

Valhalla, New York, United States and 381 other locations

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Active, not recruiting
Asthma
Biological: GSK3511294 (Depemokimab)
Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

New Haven, Connecticut, United States and 419 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Enrolling
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

North Haven, Connecticut, United States and 192 other locations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Enrolling
Asthma
Drug: Albuterol sulfate
Drug: TEV-56248

Phase 3

Teva Pharmaceuticals
Teva Pharmaceuticals

Hawthorne, New York, United States and 292 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Hawthorne, New York, United States and 95 other locations

The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.Changes will...

Enrolling
Asthma
Biological: Benralizumab
Biological: Placebo

Phase 4

AstraZeneca
AstraZeneca

Port Jefferson Station, New York, United States and 52 other locations

The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to...

Enrolling
Netherton Syndrome
Drug: ATR12-351

Phase 1

Azitra

New Haven, Connecticut, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems